Accessibility Menu
Amarin Plc logo

Amarin Plc

(NASDAQ) AMRN

Current Price$15.07
Market Cap$312.16M
Since IPO (1993)-100%
5 Year-88%
1 Year+63%
1 Month-4%

Amarin Plc Financials at a Glance

Market Cap

$312.16M

Revenue (TTM)

$183.87M

Net Income (TTM)

$38.80M

EPS (TTM)

$-1.88

P/E Ratio

-7.97

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$15.07

Volume

0

Open

$14.90

Previous Close

$15.07

Daily Range

$14.82 - $15.12

52-Week Range

$7.52 - $20.90

AMRN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amarin Plc

Industry

Biotechnology

Employees

80

CEO

Aaron D. Berg

Headquarters

Dublin, 2, IE

AMRN Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

-13%

Net Income Margin

-21%

Return on Equity

-8%

Return on Capital

-5%

Return on Assets

-6%

Earnings Yield

-12.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$312.16M

Shares Outstanding

20.81M

Volume

0

Short Interest

0.00%

Avg. Volume

90.18K

Financials (TTM)

Gross Profit

$120.87M

Operating Income

$13.94M

EBITDA

$41.54M

Operating Cash Flow

$6.74M

Capital Expenditure

$0.00

Free Cash Flow

$6.74M

Cash & ST Invst.

$302.79M

Total Debt

$12.16M

Amarin Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$19.44M

-68.8%

Gross Profit

$23.17M

+342.2%

Gross Margin

1.19%

N/A

Market Cap

$312.16M

N/A

Market Cap/Employee

$1.14M

N/A

Employees

275

N/A

Net Income

$1.22M

+97.5%

EBITDA

$7.11M

+80.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$290.63M

+1.4%

Accounts Receivable

$126.83M

+3.7%

Inventory

$195.91M

+18.0%

Long Term Debt

$12.16M

+57.5%

Short Term Debt

$0.00

N/A

Return on Assets

-5.78%

N/A

Return on Invested Capital

-4.90%

N/A

Free Cash Flow

$15.28M

+215.4%

Operating Cash Flow

$15.28M

+215.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALTAltimmune, Inc.
$3.42+0.00%
SLNSilence Therapeutics plc
$6.38-3.77%
ACIUAC Immune S.A.
$2.95-4.53%
CLLSCellectis S.A.
$3.48+0.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$75.91+0.01%
IBITiShares Bitcoin Trust
$39.82-0.01%

Questions About AMRN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.